Skip to main content

Open Questions, Unsolved Problems and Limits of FIT

  • Chapter
  • 59 Accesses

Abstract

If delayed-acting insulin is injected twice daily, either NPH, lente or ultralente insulins can be used for basal substitution. We have also studied proinsulin in an intraindividual comparative study and found it to be very well-suited for this purpose. Unfortunately, the production of proinsulin was discontinued. Its controversial cardiovascular side effects have never been investigated under controlled conditions in type I diabetic patients.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Howorka, K. (1996). Open Questions, Unsolved Problems and Limits of FIT. In: Functional Insulin Treatment. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79997-6_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-79997-6_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-60352-8

  • Online ISBN: 978-3-642-79997-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics